115 related articles for article (PubMed ID: 5017373)
1. Plasma protein binding of diphenylhydantoin in patients with epilepsy. Agreement between the unbound fraction in plasma and the concentration in the cerebrospinal fluid.
Lund L; Berlin A; Lunde KM
Clin Pharmacol Ther; 1972; 13(2):196-200. PubMed ID: 5017373
[No Abstract] [Full Text] [Related]
2. Plasma concentrations of unbound phenytoin in the management of epilepsy.
Kilpatrick CJ; Wanwimolruk S; Wing LM
Br J Clin Pharmacol; 1984 May; 17(5):539-46. PubMed ID: 6733002
[TBL] [Abstract][Full Text] [Related]
3. Plasma albumin concentration and diphenylhydantoin binding in man.
Porter RJ; Layzer RB
Arch Neurol; 1975 May; 32(5):298-303. PubMed ID: 237499
[TBL] [Abstract][Full Text] [Related]
4. Two-fold interindividual variation in plasma protein binding of phenytoin in patients with epilepsy.
Barth N; Alván G; Borgå O; Sjöqvist F
Clin Pharmacokinet; 1976; 1(6):444-52. PubMed ID: 1024769
[TBL] [Abstract][Full Text] [Related]
5. Predictability of unbound antiepileptic drug concentrations in children treated with valproic acid and phenytoin.
Miles MV; Snead OC; Thorn MD
Clin Pharm; 1988 Sep; 7(9):688-93. PubMed ID: 3149223
[No Abstract] [Full Text] [Related]
6. [Monitoring of plasma diphenylhydantoin levels in epileptic patients].
Lezama-Dávila CM; Olmos-García de Alba G; López-Anaya A; Valarezo-Crespo F
Bol Med Hosp Infant Mex; 1983 May; 40(5):256-61. PubMed ID: 6871012
[No Abstract] [Full Text] [Related]
7. Effect of valproate on free plasma phenytoin concentrations.
Tsanaclis LM; Allen J; Perucca E; Routledge PA; Richens A
Br J Clin Pharmacol; 1984 Jul; 18(1):17-20. PubMed ID: 6430316
[TBL] [Abstract][Full Text] [Related]
8. Diphenylhydantoin as an anticonvulsant: protein binding and fluctuation of the serum and cerebrospinal fluid levels in forty mentally subnormal epileptics.
Viukari NM; Tammisto P
J Ment Defic Res; 1969 Dec; 13(4):235-44. PubMed ID: 4983146
[No Abstract] [Full Text] [Related]
9. Plasma protein binding of phenytoin in 100 epileptic patients.
Peterson GM; McLean S; Aldous S; Von Witt RJ; Millingen KS
Br J Clin Pharmacol; 1982 Aug; 14(2):298-300. PubMed ID: 7104186
[TBL] [Abstract][Full Text] [Related]
10. Phenytoin-valproate interaction: importance of saliva monitoring in epilepsy.
Knott C; Hamshaw-Thomas A; Reynolds F
Br Med J (Clin Res Ed); 1982 Jan; 284(6308):13-6. PubMed ID: 6797618
[TBL] [Abstract][Full Text] [Related]
11. Human brain, cerebrospinal fluid, and plasma concentrations of diphenylhydantoin and phenobarbital.
Vajda F; Williams FM; Davidson S; Falconer MA; Breckenridge A
Clin Pharmacol Ther; 1974 Jun; 15(6):597-603. PubMed ID: 4841972
[No Abstract] [Full Text] [Related]
12. [Diphenylhydantoin in the comprehensive treatment of epileptic attacks].
Kolínová M; Kristof M; Maresová S
Cesk Neurol Neurochir; 1982 Nov; 45(6):410-7. PubMed ID: 7151206
[No Abstract] [Full Text] [Related]
13. [Clinical significance of blood levels of diphenylhydantoin orally administered to epileptic patients].
Ma ZZ
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Jun; 18(3):136-8. PubMed ID: 4053817
[No Abstract] [Full Text] [Related]
14. Variability of phenytoin protein binding in epileptic patients.
DeMonaco HJ; Lawless LM
Arch Neurol; 1983 Aug; 40(8):481-3. PubMed ID: 6347141
[TBL] [Abstract][Full Text] [Related]
15. The value of serum diphenylhydantoin (phenytoin) levels in the management of epilepsy.
Reynolds EH
Proc R Soc Med; 1975 Feb; 68(2):102-4. PubMed ID: 1166035
[No Abstract] [Full Text] [Related]
16. Serum protein binding of diphenylhydantoin in healthy man.
Lecchini S; Gatti G; Caravaggi M; De Bernardi M; Calzetti S; Visintini D; Frigo GM
Boll Soc Ital Biol Sper; 1977 Sep; 53(17):1459-62. PubMed ID: 607956
[No Abstract] [Full Text] [Related]
17. [A laboratory method for the control of diphenylhydantoin treatment (author's transl)].
Salazar T; Novoa F; Salinas A
Rev Med Chil; 1976 May; 104(5):301-5. PubMed ID: 968238
[No Abstract] [Full Text] [Related]
18. [Plasma concentration of phenytoin in epileptics--importance for the clinician].
Deonna T; de Crousaz G; Magrini G; Bechtel P; Schelling JL
Schweiz Med Wochenschr; 1975 Jul; 105(30):936-41. PubMed ID: 1153992
[TBL] [Abstract][Full Text] [Related]
19. [Anti epileptic therapy with diphenylhydantoin with serum controls in childhood. Clinical experiences].
Nolte R; Brügmann G; Besch W
Bibl Psychiatr; 1975; (151):43-8. PubMed ID: 1156347
[No Abstract] [Full Text] [Related]
20. Plasma protein binding, plasma concentrations, and effects of diphenylhydantoin in man.
Lund L; Lunde PK; Rane A; Borga O; Sjöqvist F
Ann N Y Acad Sci; 1971 Jul; 179():723-8. PubMed ID: 4998913
[No Abstract] [Full Text] [Related]
[Next] [New Search]
